Increased circulating levels of PTX3 were observed in myeloproliferative neoplasms (124), soft tissue sarcomas (125), lung cancers (126–128), pancreatic carcinomas (129), gliomas (130), and hepatocellular carcinomas (131). This evidence concerns the gene PTX3 and exocrine pancreatic carcinoma.